Left Heart Dysfunction in Acromegaly Revealed by Novel Echocardiographic Methods

Beata Uziȩbło-Życzkowska1, Agnieszka Jurek1, Przemysław Witek2,3

  • 1Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland.

Insights

Speckle-tracking echocardiography detects subclinical left heart dysfunction in acromegaly patients. This advanced imaging reveals impaired left ventricular and left atrial function, even with controlled blood pressure, highlighting cardiovascular risks in acromegaly.

Area of Science:

  • Cardiology
  • Endocrinology
  • Medical Imaging

Background:

  • Acromegaly, a rare disease, increases mortality risk, primarily from vascular causes.
  • Identifying cardiovascular risk in acromegaly patients is challenging.
  • Speckle-tracking echocardiography (STE) offers sensitive assessment of myocardial contractility and cardiac function.

Purpose of the Study:

  • To evaluate the diagnostic utility of STE in detecting left ventricular (LV) and left atrial (LA) functional impairment in acromegaly patients.
  • To compare cardiac function in acromegaly patients versus a control group without the disease.

Main Methods:

  • Echocardiographic assessment of LV and LA function using STE in 60 subjects (30 acromegaly patients, 30 matched controls).
  • Subjects were matched for age, gender, blood pressure, and hypertension history.

Main Results:

  • Acromegaly patients exhibited higher left ventricular mass and increased LV hypertrophy compared to controls.
  • Impaired LV systolic function was observed in acromegaly patients, evidenced by reduced left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS).
  • Acromegaly patients showed greater LA dimensions and indexed volume, with impaired STE-derived LA function parameters.

Conclusions:

  • Acromegaly is associated with subclinical left ventricular hypertrophy and impaired mechanical function of the LV and LA, detectable by STE.
  • These cardiac impairments can occur even in young acromegaly patients with controlled blood pressure.
  • Further research is needed to establish the prognostic significance of STE findings in acromegaly.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
249
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
300
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
264
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
306
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
128
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
128